Avastin found effective against macular degeneration
Sunday 08 May 2011
The anti-cancer drug Avastin is as effective in fighting macular degeneration as Lucentis, which, however is 40 times more expensive than the cancer fighting medicine, according to results of clinical trials published in the United States.
The study compares Avastin (bevacizumab) to Lucentis (ranibizumab), which both have been developed by US firm Genentech, owned by Swiss laboratory Roche.
During the trials, scientists randomly assigned 1,208 patients with neovascular macular degeneration - a condition that leads to the gradual loss of central vision - to receive injections in the eye of ranibizumab or bevacizumab on either a monthly schedule or as needed with monthly evaluation.
"At one year, bevacizumab and ranibizumab had equivalent effects on visual acuity when administered according to the same schedule," reported the authors of the study, including Doctor Juan Grunwald from the University of Pennsylvania.
"Ranibizumab given as needed with monthly evaluation had effects on vision that were equivalent to those of ranibizumab administered monthly."
However, the costs of the treatments were vastly different.
The average cost in the ranibizumab group per patient was $23,400 compared to $385 per patient in the bevacizumab group, the researchers said.
The study appears in the latest issue of The New England Journal of Medicine.
Life & Style blogs
Revenge porn: What is it – and how big is the problem?
Teenagers irritable because early school hours mess with their biological clocks
Paris Fashion Week: Karl Lagerfeld leads a feminist riot on 'Boulevard Chanel'
The Fappening: After the third wave of leaked celebrity photos, why can't we stop it?
Windows 10 release: Microsoft bypasses 'Windows 9' with new operating system
- 1 Snoop Dogg and Jared Leto buy a stake in Reddit as A-list invests $50m
- 2 HeForShe campaign: Iceland to follow up Emma Watson speech with UN women's rights conference – for men only
- 3 Car tax disc changes: Two days to go - and they affect you much more than just not displaying a piece of paper
- 4 Ed Sheeran dedicates song to David Cameron
- 5 Now we know whose fault it is if you end up being murdered in Thailand
- < Previous
- Next >
£18000 - £23000 per annum + Uncapped OTE: SThree: SThree Group have been well ...
£18000 - £23000 per annum + OTE: SThree: Real Staffing Group is seeking Traine...
£120 - £140 per day: Randstad Education Leeds: We have an exciting opportunity...
Competitive: Randstad Education Manchester: SEN Teacher urgently required for ...